Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, Matsumoto S. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19. J Clin Med. 2020. 9. 11. 3630
Sakemi R, Mitsuyama K, Morita M, Yoshioka S, Kuwaki K, Tokuyasu H, Fukunaga S, Mori A, Araki T, Yoshimura T, Yamasaki H, Tsuruta K, Morita T, Yamasaki S, Mizoguchi A, Sou S, Torimura T. Altered serum profile of the interleukin-22 system in inflammatory bowel disease. Cytokine. 2020. 136. 155264
Yoshioka S, Mitsuyama K, Hirai F, Esaki M, Araki T, Morita M, Yoshimura T, Mori A, Yamauchi R, Kuwaki K,Torimura T. Usefulness of ACP 353 (anti-Crohn?s disease peptide 353) as a new biomarker in the diagnosis of inflammatory bowel disease: A multicenterstudy. 27th United European Gastroenterology Week(UEGW 2019). 2019
Yamasaki H, Kinugasa T, Iwasaki S, Yoshioka S, Mizuochi T, Ishibashi M, Nagatsuka K, Yamauchi R, Ishibashi N, Araki T, Mori A, Akagi Y, Mitsuyama K, Torimura T. Questionnaire Survey from the 1st Kurume University Inflammatory Bowel Disease Center Educational Lecture. Kurume Med J. 2019. 25. 65. 109-112